Changes in management of mediastinal tumours following the surge of COVID-19 pandemic (Ongoing)

Posted On 2020-12-31 16:20:17



This series on “Changes in management of mediastinal tumours following the surge of COVID-19 pandemic” is edited by Dr. Giuseppe Banna, MD, Department of Medical Oncology, Portsmouth Hospitals NHS Trust, Portsmouth, UK and Dr. Alfredo Addeo, MD, Oncology Department, University Hospital Geneva, Geneva, Switzerland.


Editorial
The clinical fallout of organizational resilience in oncology during the pandemic
Alfredo Addeo, Giuseppe L. Banna

Review Article
Surgery for recurrent thymoma during the COVID-19 pandemic: a narrative review
Rajdeep Bilkhu, Andrea Billè

Systemic treatments for thymic tumors: a narrative review
Paolo Andrea Zucali, Fabio De Vincenzo, Matteo Perrino, Nunzio Digiacomo, Nadia Cordua, Federica D’Antonio, Federica Borea, Armando Santoro

Targeted therapies for unresectable stage III non-small cell lung cancer
Jordi Remon, Lizza E. L. Hendriks

A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic
Pasquale Pisapia, Francesco Pepe, Valerio Gristina, Maria La Mantia, Vincenzo Francomano, Gianluca Russo, Antonino Iaccarino, Antonio Galvano

The use of aerosol generating procedures (AGPs) during the COVID-19 pandemic in the diagnosis of lung cancer: a narrative review
Siyamini Vythilingam, Matthew Quint, Richard Newsom, Alexander Hicks


More are coming


Disclosure:
The series “Changes in management of mediastinal tumours following the surge of COVID-19 pandemic” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Drs Giuseppe Banna and Alfredo Addeo are serving as the unpaid Guest Editor for the series.